Imeik Technology Development Co.,Ltd. Imeik Technology Development Co.,Ltd.

Imeik Technology Development Co.,Ltd.

300896

Rang in aandelen #3834
Imeik Technology Development Co.,Ltd. specializes in the research, development,... Imeik Technology Development Co.,Ltd. specializes in the research, development, manufacturing, and distribution of biomedical materials. The company's diverse product portfolio caters to both the medical aesthetics field and general skincare needs. Within its medical beauty offerings, Imeik provides a range of recognized brands including Moisten Angel, IFRESH, Yimei, Hearty, Bonita Bonita, and Tightly. Additionally, its comprehensive skincare line features hydrating lotions, anti-aging and firming serums, concentrated essence creams, revitalizing facial masks, restorative chitosan B5 sprays, and clarifying and illuminating liquids. Established in 2004, the company's operations are based in Beijing, China.
Aandeelprijs
$14.36
Marktkapitalisatie
$4.35B
Verandering (1 dag)
0.22%
Verandering (1 jaar)
-39.05%
Land
CN
Handel Imeik Technology Development Co.,Ltd. (300896)

Categorie

Healthcare
Winst voor Imeik Technology Development Co.,Ltd. (300896)
Winst in Jun 2026 TTM: $187.62M
Volgens de meest recente financiële verslagen van Imeik Technology Development Co.,Ltd. bedraagt de huidige winst van het bedrijf $187.62M. In 2023 behaalde het bedrijf een winst van $304.52M, een stijging ten opzichte van de winst van 2022, die $215.76M bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van Imeik Technology Development Co.,Ltd. van 2014 tot 2026
Winst aan het einde van elk jaar
Jaar Winst Wijzigen
2026 (TTM) $187.62M -39.96%
2024 $312.51M 2.62%
2023 $304.52M 41.14%
2022 $215.76M 22.24%
2021 $176.50M 129.39%
2020 $76.94M 52.74%
2019 $50.38M 142.00%
2018 $20.82M 44.54%
2017 $14.40M 57.61%
2016 $9.14M 113.72%
2015 $4.28M -22.82%
2014 $5.54M 0.00%
Winst van vergelijkbare bedrijven of concurrenten
Bedrijf Winst Winstverschil Land
$3.81B 1,928.49%
US
$4.11B 2,090.02%
FR
- -
JP
$1.59B 747.47%
US
- -
CH